Skip to content
healthcare.dev
Get a free key

ZELAPAR

NDC 0187-0453, SELEGILINE HYDROCHLORIDE, tablet, orally disintegrating, from Bausch Health US, LLC.

Product NDC
0187-0453
Status
Listed
Labeler
Bausch Health US, LLC
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021479
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0187-0453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEGILINE HYDROCHLORIDE1.25 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]

Package NDCNDC-11Package
0187-0453-02001870453026 POUCH in 1 CARTON (0187-0453-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/380d7717-2a79-42f3-a712-efe5e7696ba0

Use it

Look up 0187-0453 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0187-0453 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0187-0453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.